The common cold is caused by viruses, not by cold weather itself. Rhinoviruses are responsible for the majority of cases, causing up to 80% of colds during peak season in the fall. But rhinoviruses aren’t alone. With 167 known rhinovirus serotypes split across three groups, plus contributions from coronaviruses, adenoviruses, and other viral families, the sheer number of circulating strains explains why you keep catching colds year after year.
Rhinoviruses and the Other Culprits
Rhinoviruses dominate. Scientists have cataloged 83 serotypes in the A group, 32 in the B group, and 55 in the newer C group. Each serotype is different enough that your immune system treats it as a new threat. That’s 167 versions of just one virus family, and catching one gives you little protection against the next.
The remaining 20% to 40% of colds come from other virus families. Certain coronaviruses (not the one behind COVID-19, but milder relatives), respiratory syncytial virus, parainfluenza viruses, and adenoviruses all produce the familiar constellation of sneezing, congestion, and sore throat. In roughly a quarter of cases, no specific virus is ever identified. The practical takeaway: “the common cold” isn’t one disease. It’s a symptom pattern triggered by dozens of different pathogens.
How the Virus Gets Inside Your Cells
About 90% of rhinovirus serotypes use the same entry point: a protein on the surface of your nasal lining cells called ICAM-1. This protein normally helps immune cells communicate, but rhinoviruses have evolved to latch onto it like a key fitting a lock. Once the virus binds, the cell pulls it inside, and the virus hijacks the cell’s machinery to make copies of itself.
Here’s the twist. When your immune system detects the infection, it triggers inflammation, and inflammation causes your cells to produce more ICAM-1. That means the immune response itself creates more docking stations for the virus, helping it spread to neighboring cells. It’s a clever evolutionary trick: the harder your body fights, the more entry points the virus gets.
Why Cold Weather Actually Matters
Your grandmother was partly right. Cold weather doesn’t directly cause a cold (you still need the virus), but cooler temperatures tilt the playing field in the virus’s favor. Research from Yale found that rhinoviruses replicate more efficiently at the temperature inside your nose, which is a few degrees cooler than your core body temperature, compared to the warmer environment of your lungs.
The key finding wasn’t about the virus itself. It was about your immune system. At lower temperatures, the innate immune response, your body’s first line of defense, becomes sluggish. Cells are slower to detect the virus and slower to mount an antiviral response. When researchers tested the virus in cells that lacked immune defenses entirely, it replicated just fine at higher temperatures too. That confirmed the problem isn’t that cold air supercharges the virus. It’s that cold air weakens your defenses.
This helps explain the seasonal pattern. In winter, you breathe cold air that chills the nasal lining, your local immune response dips, and you’re simultaneously spending more time indoors in close contact with other people. The combination is what drives cold season, not temperature alone.
How Colds Spread From Person to Person
Close contact is the primary route. When someone with a cold coughs, sneezes, or even talks, they release tiny droplets containing virus particles. If you’re nearby, you can inhale those droplets directly. Shaking hands with a sick person and then touching your nose or eyes is another extremely common path.
Surface transmission plays a supporting role. Cold viruses can survive on hard surfaces for several hours to days, depending on the specific virus, humidity, temperature, and the type of surface. You can pick up the virus from a doorknob or phone screen that someone sneezed on minutes earlier. Hard, nonporous surfaces tend to keep viruses infectious longer than fabrics.
The timeline is important for avoiding spread. The incubation period is short, just 12 hours to three days after exposure. You can start spreading the virus a day or two before symptoms appear, and you remain contagious for up to two weeks. But the highest risk window is the first three days of feeling sick, when symptoms peak and viral shedding is heaviest.
Why Some People Catch Colds More Easily
Exposure to the virus is necessary, but whether you actually get sick depends heavily on the state of your immune system at the time. Sleep is one of the strongest predictors. A study published in Archives of Internal Medicine found that people sleeping fewer than seven hours per night were nearly three times more likely to develop a cold after being exposed to rhinovirus compared to those getting eight or more hours. Sleep quality mattered even more: participants with poor sleep efficiency (meaning they spent a lot of time in bed but not actually sleeping) were 5.5 times more likely to get sick.
Chronic stress, poor nutrition, and smoking all suppress immune function in ways that make you more vulnerable. Age plays a role too. Young children catch more colds, partly because their immune systems haven’t encountered as many strains yet, and partly because daycares and schools are ideal environments for viral transmission.
Why You Can’t Build Lasting Immunity
Unlike diseases such as measles, where one infection grants lifelong protection, colds offer only brief and narrow immunity. After recovering from a specific rhinovirus strain, your body produces antibodies against it. But that protection doesn’t reliably extend to other strains.
A controlled study illustrates this clearly. Researchers infected volunteers with one rhinovirus strain (RV-A16) and then re-exposed them 15 weeks later to either the same strain or a closely related one (RV-A39). Re-challenge with the same strain cut infection rates roughly in half, from 88% down to 46%. But exposure to the related strain infected people at the full rate, as if they’d never been sick at all. Even more surprising, higher antibody levels from the first infection were actually associated with more viral shedding during the second, different infection. Pre-existing antibodies didn’t just fail to help against a new strain; they may have interfered with the immune response.
With 167 rhinovirus serotypes alone and dozens of other cold-causing viruses circulating, your immune system simply can’t keep up. This is also the core reason there’s no vaccine for the common cold. A vaccine would need to protect against an enormous and constantly shifting roster of targets.
Telling a Cold Apart From the Flu
Colds and flu share enough symptoms that it can be difficult, sometimes impossible, to distinguish them without testing. Both cause coughing, sore throat, congestion, and fatigue. But the pattern differs. Colds tend to come on gradually and center around the nose: runny nose, sneezing, and stuffiness are the dominant features. Fever is uncommon in adults with colds.
Flu hits harder and faster. Symptoms appear abruptly and are more intense, with high fever, significant body aches, headaches, and deep fatigue. Flu can also lead to serious complications like pneumonia and hospitalization, which colds almost never cause. If your symptoms came on suddenly and you feel flattened, that points more toward flu than a cold.
The Scale of the Problem
The common cold is easily the most frequent infectious disease in humans. In the United States alone, colds drive more than 100 million doctor visits each year. Americans spend roughly $2.9 billion annually on over-the-counter cold remedies and another $400 million on prescriptions. An estimated $1.1 billion goes toward antibiotic prescriptions for cold sufferers, despite the fact that antibiotics do nothing against viruses.
The indirect costs are even larger. Nearly 190 million school days are lost to colds each year, and parents miss an additional 126 million workdays to care for sick children. Combined with workdays lost by sick employees, cold-related productivity losses exceed $20 billion annually. The total economic burden, including healthcare and lost productivity, reaches an estimated $40 billion per year in the U.S. alone.